Elon Musk on Tuesday said he doesn’t see Nvidia’s new self-driving tools as a problem for Tesla right after the latter’s CEO Jensen Huang introduced Alpamayo atElon Musk on Tuesday said he doesn’t see Nvidia’s new self-driving tools as a problem for Tesla right after the latter’s CEO Jensen Huang introduced Alpamayo at

Elon Musk said Nvidia’s new autonomous models will not pressure Tesla’s Full Self-Driving system for at least five to six years

2026/01/08 05:10
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

Elon Musk on Tuesday said he doesn’t see Nvidia’s new self-driving tools as a problem for Tesla right after the latter’s CEO Jensen Huang introduced Alpamayo at CES in Vegas.

The Alpamayo system is supposed to help cars think like people, but Elon didn’t sound impressed. An X user compared it to Tesla’s Full Self-Driving, and Elon replied that it’ll take “many years” before any system beats a human behind the wheel.

“The legacy car companies won’t design the cameras and AI computers into their cars at scale until several years after that,” Elon responded in a post. “So this is maybe a competitive pressure on Tesla in 5 or 6 years, but probably longer.”

Elon throws shade while Jensen stays polite

Elon didn’t just brush it off once. In another post, he said Nvidia will find it “easy to get to 99% and then super hard to solve the long tail of the distribution.” That 1% at the end? That’s where everyone’s been stuck.

Jensen, though, always keeps it friendly. During a Q&A, he called Tesla’s FSD stack “world-class” and “state-of-the-art.” But he also pointed out the difference. “Our system is really quite pervasive because we’re a technology platform provider. That’s the primary difference,” he said.

Translation: Nvidia gives the software to car companies. Tesla builds the cars.

Tesla already has a small robotaxi service in Austin. There’s also one in San Francisco, but there’s still a driver in the car. Elon said last August they’re training a new FSD model. He’s been talking about self-driving cars for years. It’s still supervised. But they’re testing it.

Long history, joint deals, and billions at stake

Back in 2016, nobody cared about Nvidia’s DGX-1 supercomputer except for the nerdy Elon. He [famously] was the first buyer, and Jensen delivered it himself, sealing what seems to be a decade-long friendship as of 2026.

Back then, Jensen once said Elon is the “ultimate GPU” because of how fast he handles big projects. Elon liked his work ethic and called it “hardcore.”

That same DGX-1 machine became part of OpenAI’s early research, and then Tesla used Nvidia’s chips in the first version of its FSD computer.

Jensen once said he regrets not giving Elon more funding for xAI, so now Nvidia is backing it, building a giant data center called Colossus II for xAI, packed with Nvidia GPUs.

The two boys are also working on a huge project in Saudi Arabia with a local startup called Humain AI, something Cryptopolitan previously reported live.

Claim your free seat in an exclusive crypto trading community - limited to 1,000 members.

Market Opportunity
Dogelon Mars Logo
Dogelon Mars Price(ELON)
$0.00000003741
$0.00000003741$0.00000003741
-0.08%
USD
Dogelon Mars (ELON) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09